Cargando…

Human Platelets and Derived Products in Treating Ocular Surface Diseases – A Systematic Review

Human platelet products have emerged as an alternative treatment for a range of ocular surface diseases such as dry eye and corneal ulceration. With significant therapeutic potential and increasing popularity, this study aimed to conduct a systematic review to detail the various production methods i...

Descripción completa

Detalles Bibliográficos
Autores principales:	You, Jingjing, Hodge, Chris, Hoque, Monira, Petsoglou, Constantinos, Sutton, Gerard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7567560/ https://www.ncbi.nlm.nih.gov/pubmed/33116370 http://dx.doi.org/10.2147/OPTH.S265701

Ejemplares similares

Development of an In Situ Printing System With Human Platelet Lysate-Based Bio-Adhesive to Treat Corneal Perforations
por: You, Jingjing, et al.
Publicado: (2022)

Application of Collagen I and IV in Bioengineering Transparent Ocular Tissues
por: Song, Yihui, et al.
Publicado: (2021)

Immunomodulatory Effects of Bone Marrow-Derived Mesenchymal Stem Cells on Pro-Inflammatory Cytokine-Stimulated Human Corneal Epithelial Cells
por: Wen, Li, et al.
Publicado: (2014)

Development of a Platelet Lysate–Based Printable, Transparent Biomaterial With Regenerative Potential for Epithelial Corneal Injuries
por: Frazer, Hannah, et al.
Publicado: (2020)

Expression of HGF and c-Met Proteins in Human Keratoconus Corneas
por: You, Jingjing, et al.
Publicado: (2015)

Corrigendum to “Expression of HGF and c-Met Proteins in Human Keratoconus Corneas”
por: You, Jingjing, et al.
Publicado: (2016)

Tear levels of SFRP1 are significantly reduced in keratoconus patients
por: You, Jingjing, et al.
Publicado: (2013)

Tribology and the Ocular Surface
por: Lievens, Chris W, et al.
Publicado: (2022)

Pegylated interferon-alpha-2a for the treatment of ocular surface squamous neoplasia
por: Nuruddin, Murtuza, et al.
Publicado: (2022)

Effect of Autologous Platelet-Rich Plasma Drops in the Treatment of Ocular Surface Disease
por: Nadelmann, Jennifer B, et al.
Publicado: (2022)

Case Series of Rare Fungal Keratitides: Experiences from a Quaternary Eye Hospital in Sydney, Australia
por: Xuan, Rachel, et al.
Publicado: (2023)

Treating ocular surface disease: new agents in development
por: Fahmy, Ahmad M, et al.
Publicado: (2011)

Mesenchymal stem cells for treating ocular surface diseases
por: Zhang, Liyun, et al.
Publicado: (2015)

Ocular Surface Changes in Prostaglandin Analogue-Treated Patients
por: Shen, Wencui, et al.
Publicado: (2019)

Gut-derived butyrate suppresses ocular surface inflammation
por: Schaefer, Laura, et al.
Publicado: (2022)

RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients
por: You, Jingjing, et al.
Publicado: (2018)

Author Correction: RNA-Seq analysis and comparison of corneal epithelium in keratoconus and myopia patients
por: You, Jingjing, et al.
Publicado: (2021)

To See or Not to See: A Systematic Review of the Importance of Human Ocular Surface Cytokine Biosignatures in Ocular Allergy
por: Aydin, Esrin, et al.
Publicado: (2019)

Proton Sensing on the Ocular Surface: Implications in Eye Pain
por: Comes, Núria, et al.
Publicado: (2021)

Platelet derived growth factor inhibitors: A potential therapeutic approach for ocular neovascularization
por: Sadiq, Mohammad Ali, et al.
Publicado: (2015)

Effects of the Surface Charge of Graphene Oxide Derivatives on Ocular Compatibility
por: Rong, Liyuan, et al.
Publicado: (2022)

Ocular Surface Potential Difference Measured in Human Subjects to Study Ocular Surface Ion Transport
por: Pasricha, Neel D., et al.
Publicado: (2020)

Impact of Microplastics on the Ocular Surface
por: Wu, Duoduo, et al.
Publicado: (2023)

Autologous Platelet-Rich Plasma Eye Drops for the Treatment of Post-LASIK Chronic Ocular Surface Syndrome
por: Alio, Jorge L., et al.
Publicado: (2017)

Mean Platelet Volume in Ocular Behçet's Disease
por: Türkcü, Fatih Mehmet, et al.
Publicado: (2013)

Atropine Differentially Modulates ECM Production by Ocular Fibroblasts, and Its Ocular Surface Toxicity Is Blunted by Colostrum
por: Cristaldi, Martina, et al.
Publicado: (2020)

Update and clinical utility of the LenSx femtosecond laser in cataract surgery
por: Roberts, Timothy V, et al.
Publicado: (2016)

Ocular surface tumors
por: Varde, Meghana Anika, et al.
Publicado: (2009)

Ocular surface tumors
por: Othman, Ihab Saad
Publicado: (2009)

Ocular surface leproma
por: Ram, J, et al.
Publicado: (2018)

Author Correction: Gut-derived butyrate suppresses ocular surface inflammation
por: Schaefer, Laura, et al.
Publicado: (2022)

Advances in Diagnosis and Treatment of HPV Ocular Surface Infections
por: D. Kalogeropoulos, Chris, et al.
Publicado: (2015)

A systematic review on the impact of diabetes mellitus on the ocular surface
por: Shih, K Co, et al.
Publicado: (2017)

Ocular surface disease in patients with glaucoma or ocular hypertension treated with either BAK-preserved latanoprost or BAK-free travoprost
por: Katz, Gregory, et al.
Publicado: (2010)

Angiogenesis Is Differentially Modulated by Platelet-Derived Products
por: Berndt, Sarah, et al.
Publicado: (2021)

Ocular surface chemical injury treated by regenerating agent (RGTA, Cacicol20)
por: Ustaoglu, Melih, et al.
Publicado: (2017)

The Ocular Surface Characteristics in Prostate Cancer Patients Treated with Androgen Deprivation Therapy
por: Li, Weina, et al.
Publicado: (2021)

Latanoprost PF vs. Bimatoprost PF: Which Treats the Ocular Surface Better?
por: Dimtsas, Georgios S., et al.
Publicado: (2023)

Visual Outcomes and Higher Order Aberrations Following LASIK on Eyes with Low Myopia and Astigmatism
por: Agarwal, Smita, et al.
Publicado: (2018)

β-Thalassemia and ocular implications: a systematic review
por: Liaska, Aliki, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_8r4m7irjlrf623bm4en95s329n